Vaxart Announces Initiation of Bivalent Norovirus Vaccine Phase 1b Clinical Trial – BioSpace

Vaxart Announces Initiation of Bivalent Norovirus Vaccine Phase 1b Clinical Trial  BioSpace

First Dosing with Norovirus GII.4 Oral Tablet Vaccine Scheduled for Week of March 18 -. SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Vaxart, Inc., …

Share this post:

Recent Posts